Alkermes plc · Health Care
ALKS
$52.72
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall.Alkermesplc是一家完全整合的生物制药公司，专注于开发治疗精神及神经疾病的药物。公司由MichaelWall于1987年创立。
Quality compounder优质复利股
Mid cap中盘
$9B
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
The bottoming setup is not yet confirmed (price still below the 10-day average) and oscillators are already extended/ove筑底形态尚未确认（价格仍位于 10 日均线下方），且摆动指标已过热——此处入场风险较高。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Key Statistics关键统计
Price价格
$52.72
4.5% below 52-week high低于52周高点 4.5%
Market Cap市值
$9B
Normal volume正常成交量
P/E Ratio市盈率
36.1x
28.9x sector median
Beta贝塔
0.70
Moves about 0.7x the market波动幅度约为市场的 0.7 倍
RSI (14)RSI（14）
63
Elevated偏高
Next Earnings下次财报
2026-08-04 (16d)
Volatility Rank波动率分位
77th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
10.6% of float
Performance价格表现
| Period周期 | ALKS | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +1.5% | -1.5% | Beat the index by 3.0 points跑赢指数 3.0 个百分点 |
| 1 Month近1月 | +18.4% | +0.6% | Beat the index by 17.8 points跑赢指数 17.8 个百分点 |
| 3 Months近3月 | +52.7% | +4.7% | Beat the index by 48.0 points跑赢指数 48.0 个百分点 |
| 6 Months近6月 | +66.7% | +7.8% | Beat the index by 58.9 points跑赢指数 58.9 个百分点 |
| Year to date年初至今 | +86.6% | +9.1% | Beat the index by 77.5 points跑赢指数 77.5 个百分点 |
| 1 Year近1年 | +79.6% | +19.4% | Beat the index by 60.2 points跑赢指数 60.2 个百分点 |
| 3 Years近3年 | +67.5% | +69.4% | Lagged the index by 1.9 points落后指数 1.9 个百分点 |
Technicals技术面
RSI (14)RSI（14）
63
Elevated偏高
vs 50-day相对50日均线
+17.6% vs 50-day avg
vs 200-day相对200日均线
+52.9% vs 200-day avg
Volatility rank波动率分位
77th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$51.96
Don't chase above不追高于
$52.72
Stop止损
$44.09
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
16
days until next report天后公布财报
2026-08-04
Estimates being raised — 1 analysts预期上调 — 1 位分析师
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | ALKS | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 36.12x | 28.92 | 33% |
| P/B市净率 | 4.80x | 3.52 | 32% |
| P/S市销率 | 5.92x | 3.02 | 26% |
| Earnings yield盈利收益率 | 2.77% | 2.72 | 51% |
| FCF yield自由现金流收益率 | 5.50% | 3.94 | 70% |
| EV/EBITDA企业价值/EBITDA | 29.67x | 18.21 | 21% |
| P/FCF市值/自由现金流 | 18.18x | 22.42 | 65% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 7.3%
Earnings Per Share每股收益
Free Cash Flow自由现金流
Margins利润率
13.3%Return on Equity股本回报率
9.7%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | -1.38 |
| Current ratio流动比率 | 3.55 |
Capital Allocation资本配置
| Buybacks (TTM)回购（TTM） | $200.3M |
| Stock-based comp股权薪酬 | $98.7M |
| Share count change (1y)股数变化（1年） | +2.1% |
Piotroski皮奥特罗斯基 5/8
Altman Z阿尔特曼Z: safe (9.0)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 36% of its sector on blended multiples综合估值倍数低于行业内 36% 的公司
Beta市场敏感度
0.70×
0.21×3×
Moves about 0.7× the market波动幅度约为市场的 0.7 倍
Financial Health财务健康
5/8
Altman阿尔特曼: safe
Adequate financial health财务健康状况一般
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
ALKS took relative-strength leadershipALKS 取得相对强弱领先
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$4.2M net (0 buyers, 5 sellers)-$4.2M 净值（0 买家，5 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Baker Bros. Advisors | A | Holding持有 | 2.0% | 2026-03-31 |
| RTW Investments | B | Holding持有 | 0.6% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 17, 2026
ALKS took relative-strength leadershipALKS 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $52.72.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$52.72。
Jul 10, 2026
ALKS daily MACD crossed downALKS 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $51.94.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$51.94。
Jul 6, 2026
ALKS made a new 52-week highALKS 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $55.14.价格创出52周新高 — 全市场关注的动量/趋势极值。$55.14。
Jun 22, 2026
ALKS daily MACD crossed upALKS 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $46.02.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$46.02。
Jun 22, 2026
ALKS StochRSI turned up from oversoldALKS StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $46.02.StochRSI重回20上方 — 下行动量趋缓的最早预警。$46.02。
Jun 18, 2026
ALKS made a new 52-week highALKS 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $44.99.价格创出52周新高 — 全市场关注的动量/趋势极值。$44.99。
Jun 18, 2026
ALKS daily MACD crossed downALKS 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $44.99.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$44.99。
Jun 18, 2026
ALKS RSI reached overboughtALKS RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $44.99.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$44.99。
Jun 11, 2026
ALKS made a new 52-week highALKS 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $44.92.价格创出52周新高 — 全市场关注的动量/趋势极值。$44.92。
Jun 9, 2026
ALKS made a new 52-week highALKS 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $44.29.价格创出52周新高 — 全市场关注的动量/趋势极值。$44.29。
Jun 9, 2026
ALKS RSI reached overboughtALKS RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $44.29.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$44.29。
Showing last 15 of显示最近15条，共 240 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: 0.02
Value价值
-0.6
Quality质量
+1.7
Investment资本投入
-0.7
Low volatility低波动
-0.2
Low market beta低市场敏感度
+0.2
Earnings quality盈利质量
+1.3
Short interest空头兴趣
-0.8
Company Profile公司档案
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall.Alkermesplc是一家完全整合的生物制药公司，专注于开发治疗精神及神经疾病的药物。公司由MichaelWall于1987年创立。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Capital intensity rising
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。